Gefitinib 250 mg Australia

Gefitinib 250 mg is a targeted cancer therapy used primarily to treat non-small cell lung cancer (NSCLC) with EGFR mutations. It works by blocking signals that promote cancer cell growth. This oral tablet offers personalized treatment for eligible patients and must be used under medical supervision with regular monitoring.